European Medicines Agency’s CHMP Rejects Celgene’s Revlimid In Myelodysplastic Syndromes

 
• By Brooke McManus

Agency reiterates negative opinion on Wyeth's Mylotarg for acute myeloid leukemia.

More from Europe

More from Geography